Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Lundin Energy price target lowered to SEK 261 from SEK 283 at Deutsche Bank » 13:16
09/16/21
09/16
13:16
09/16/21
13:16
LNDNF

Lundin Energy

$31.75 /

+ (+0.00%)

Deutsche Bank analyst…

Deutsche Bank analyst James Hubbard lowered the firm's price target on Lundin Energy to SEK 261 from SEK 283 and keeps a Hold rating on the shares.

ShowHide Related Items >><<
LNDNF Lundin Energy
$31.75 /

+ (+0.00%)

09/13/21 Pareto
Lundin Energy upgraded to Buy from Hold at Pareto
08/06/21 Societe Generale
Lundin Energy price target raised to SEK 210 from SEK 205 at Societe Generale
07/30/21 Barclays
Lundin Energy price target lowered to SEK 350 from SEK 400 at Barclays
07/30/21 Berenberg
Lundin Energy price target lowered to SEK 260 from SEK 290 at Berenberg
Over a week ago
Upgrade
Lundin Energy upgraded to Buy from Hold at Pareto » 05:43
09/13/21
09/13
05:43
09/13/21
05:43
LNDNF

Lundin Energy

$30.55 /

+ (+0.00%)

Pareto analyst Johan…

Pareto analyst Johan Spetz upgraded Lundin Energy to Buy from Hold with a SEK 340 price target.

ShowHide Related Items >><<
LNDNF Lundin Energy
$30.55 /

+ (+0.00%)

08/06/21 Societe Generale
Lundin Energy price target raised to SEK 210 from SEK 205 at Societe Generale
07/30/21 Barclays
Lundin Energy price target lowered to SEK 350 from SEK 400 at Barclays
07/30/21 Berenberg
Lundin Energy price target lowered to SEK 260 from SEK 290 at Berenberg
07/16/21 Barclays
Lundin Energy price target raised to SEK 400 from SEK 360 at Barclays
Over a month ago
Recommendations
Lundin Energy price target raised to SEK 210 from SEK 205 at Societe Generale » 13:32
08/06/21
08/06
13:32
08/06/21
13:32
LNDNF

Lundin Energy

$30.95 /

-0.52 (-1.65%)

Societe Generale analyst…

Societe Generale analyst Yoann Charenton raised the firm's price target on Lundin Energy to SEK 210 from SEK 205 and keeps a Sell rating on the shares.

ShowHide Related Items >><<
LNDNF Lundin Energy
$30.95 /

-0.52 (-1.65%)

07/30/21 Barclays
Lundin Energy price target lowered to SEK 350 from SEK 400 at Barclays
07/30/21 Berenberg
Lundin Energy price target lowered to SEK 260 from SEK 290 at Berenberg
07/16/21 Barclays
Lundin Energy price target raised to SEK 400 from SEK 360 at Barclays
07/15/21 Scotiabank
Lundin Energy price target raised to SEK 350 from SEK 325 at Scotiabank
Recommendations
Lundin Energy price target lowered to SEK 350 from SEK 400 at Barclays » 14:53
07/30/21
07/30
14:53
07/30/21
14:53
LNDNF

Lundin Energy

$31.50 /

+1 (+3.28%)

Barclays analyst James…

Barclays analyst James Hosie lowered the firm's price target on Lundin Energy to SEK 350 from SEK 400 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
LNDNF Lundin Energy
$31.50 /

+1 (+3.28%)

07/30/21 Berenberg
Lundin Energy price target lowered to SEK 260 from SEK 290 at Berenberg
07/16/21 Barclays
Lundin Energy price target raised to SEK 400 from SEK 360 at Barclays
07/15/21 Scotiabank
Lundin Energy price target raised to SEK 350 from SEK 325 at Scotiabank
06/16/21 Berenberg
Lundin Energy price target raised to SEK 290 from SEK 280 at Berenberg
Recommendations
Lundin Energy price target lowered to SEK 260 from SEK 290 at Berenberg » 12:45
07/30/21
07/30
12:45
07/30/21
12:45
LNDNF

Lundin Energy

$31.50 /

+1 (+3.28%)

Berenberg analyst James…

Berenberg analyst James Carmichael lowered the firm's price target on Lundin Energy to SEK 260 from SEK 290 and keeps a Hold rating on the shares.

ShowHide Related Items >><<
LNDNF Lundin Energy
$31.50 /

+1 (+3.28%)

07/16/21 Barclays
Lundin Energy price target raised to SEK 400 from SEK 360 at Barclays
07/15/21 Scotiabank
Lundin Energy price target raised to SEK 350 from SEK 325 at Scotiabank
06/16/21 Berenberg
Lundin Energy price target raised to SEK 290 from SEK 280 at Berenberg
06/15/21 JPMorgan
Lundin Energy price target raised to SEK 322 from SEK 317 at JPMorgan
Recommendations
Lundin Energy price target raised to SEK 400 from SEK 360 at Barclays » 13:15
07/16/21
07/16
13:15
07/16/21
13:15
LNDNF

Lundin Energy

$33.99 /

+ (+0.00%)

Barclays analyst James…

Barclays analyst James Hosie raised the firm's price target on Lundin Energy to SEK 400 from SEK 360 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
LNDNF Lundin Energy
$33.99 /

+ (+0.00%)

07/15/21 Scotiabank
Lundin Energy price target raised to SEK 350 from SEK 325 at Scotiabank
06/16/21 Berenberg
Lundin Energy price target raised to SEK 290 from SEK 280 at Berenberg
06/15/21 JPMorgan
Lundin Energy price target raised to SEK 322 from SEK 317 at JPMorgan
05/06/21 RBC Capital
Lundin Energy downgraded to Sector Perform from Outperform at RBC Capital
Recommendations
Lundin Energy price target raised to SEK 350 from SEK 325 at Scotiabank » 12:04
07/15/21
07/15
12:04
07/15/21
12:04
LNDNF

Lundin Energy

$33.99 /

+ (+0.00%)

Scotiabank analyst Gavin…

Scotiabank analyst Gavin Wylie raised the firm's price target on Lundin Energy to SEK 350 from SEK 325 and keeps a Sector Perform rating on the shares.

ShowHide Related Items >><<
LNDNF Lundin Energy
$33.99 /

+ (+0.00%)

06/16/21 Berenberg
Lundin Energy price target raised to SEK 290 from SEK 280 at Berenberg
06/15/21 JPMorgan
Lundin Energy price target raised to SEK 322 from SEK 317 at JPMorgan
05/06/21 RBC Capital
Lundin Energy downgraded to Sector Perform from Outperform at RBC Capital
04/30/21 Barclays
Lundin Energy price target raised to SEK 360 from SEK 350 at Barclays
Over a quarter ago
Recommendations
Lundin Energy price target raised to SEK 290 from SEK 280 at Berenberg » 12:28
06/16/21
06/16
12:28
06/16/21
12:28
LNDNF

Lundin Energy

$36.61 /

+ (+0.00%)

Berenberg analyst James…

Berenberg analyst James Carmichael raised the firm's price target on Lundin Energy to SEK 290 from SEK 280 and keeps a Hold rating on the shares.

ShowHide Related Items >><<
LNDNF Lundin Energy
$36.61 /

+ (+0.00%)

06/15/21 JPMorgan
Lundin Energy price target raised to SEK 322 from SEK 317 at JPMorgan
05/06/21 RBC Capital
Lundin Energy downgraded to Sector Perform from Outperform at RBC Capital
04/30/21 Barclays
Lundin Energy price target raised to SEK 360 from SEK 350 at Barclays
04/30/21 Berenberg
Lundin Energy downgraded to Hold from Buy at Berenberg
Recommendations
Lundin Energy price target raised to SEK 322 from SEK 317 at JPMorgan » 12:50
06/15/21
06/15
12:50
06/15/21
12:50
LNDNF

Lundin Energy

$36.61 /

+1.6 (+4.57%)

JPMorgan analyst James…

JPMorgan analyst James Thompson raised the firm's price target on Lundin Energy to SEK 322 from SEK 317 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
LNDNF Lundin Energy
$36.61 /

+1.6 (+4.57%)

05/06/21 RBC Capital
Lundin Energy downgraded to Sector Perform from Outperform at RBC Capital
04/30/21 Barclays
Lundin Energy price target raised to SEK 360 from SEK 350 at Barclays
04/30/21 Berenberg
Lundin Energy downgraded to Hold from Buy at Berenberg
04/21/21 Barclays
Lundin Energy price target raised to SEK 350 from SEK 290 at Barclays
Conference/Events
Jefferies to hold a virtual conference » 09:39
05/21/21
05/21
09:39
05/21/21
09:39
CLPBY

Coloplast

$16.04 /

+0.3 (+1.91%)

, GSK

GlaxoSmithKline

$39.04 /

+0.327049 (+0.84%)

, KGFHY

Kingfisher

$10.59 /

-0.01 (-0.09%)

, LNDNF

Lundin Energy

$32.65 /

-1.28 (-3.77%)

, MONDY

Mondi

$55.99 /

+1.03 (+1.87%)

, NVS

Novartis

$87.93 /

+0.28 (+0.32%)

, ORAN

Orange

$12.83 /

+0.115 (+0.90%)

, PDRDY

Pernod Ricard

$43.43 /

+0.9255 (+2.18%)

, SUBCY

Subsea 7

$9.75 /

-0.13 (-1.32%)

, SXYAY

Sika

$31.24 /

+0.562 (+1.83%)

, VOPKY

Koninklijke Vopak

$46.76 /

+0.83 (+1.81%)

Structural Winners…

Structural Winners Virtual Conference will be held on May 21.

ShowHide Related Items >><<
ORAN Orange
$12.83 /

+0.115 (+0.90%)

NVS Novartis
$87.93 /

+0.28 (+0.32%)

GSK GlaxoSmithKline
$39.04 /

+0.327049 (+0.84%)

CLPBY Coloplast
$16.04 /

+0.3 (+1.91%)

05/18/21 Berenberg
Coloplast price target raised to DKK 900 from DKK 870 at Berenberg
05/07/21 JPMorgan
Coloplast price target raised to DKK 963 from DKK 912 at JPMorgan
03/09/21 Commerzbank
Coloplast upgraded to Buy from Reduce at Commerzbank
03/08/21 Barclays
Coloplast upgraded to Equal Weight from Underweight at Barclays
GSK GlaxoSmithKline
$39.04 /

+0.327049 (+0.84%)

05/11/21 UBS
GlaxoSmithKline price target raised to 1,370 GBp from 1,360 GBp at UBS
04/30/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,200 GBp at Deutsche Bank
04/20/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,550 GBp at Morgan Stanley
04/20/21 UBS
GlaxoSmithKline price target raised to 1,360 GBp from 1,320 GBp at UBS
KGFHY Kingfisher
$10.59 /

-0.01 (-0.09%)

04/15/21 Citi
Kingfisher upgraded to Neutral from Sell at Citi
03/25/21 JPMorgan
Kingfisher price target raised to 300 GBp from 260 GBp at JPMorgan
03/23/21 Morgan Stanley
Kingfisher price target raised to 360 GBp from 340 GBp at Morgan Stanley
03/22/21 Goldman Sachs
Kingfisher downgraded to Neutral from Buy at Goldman Sachs
LNDNF Lundin Energy
$32.65 /

-1.28 (-3.77%)

05/06/21 RBC Capital
Lundin Energy downgraded to Sector Perform from Outperform at RBC Capital
04/30/21 Barclays
Lundin Energy price target raised to SEK 360 from SEK 350 at Barclays
04/30/21 Berenberg
Lundin Energy downgraded to Hold from Buy at Berenberg
04/21/21 Barclays
Lundin Energy price target raised to SEK 350 from SEK 290 at Barclays
MONDY Mondi
$55.99 /

+1.03 (+1.87%)

04/16/21 UBS
Mondi price target raised to 2,160 GBp from 2,070 GBp at UBS
03/17/21 Berenberg
Mondi initiated with a Hold at Berenberg
03/16/21 JPMorgan
Mondi price target raised to 1,850 GBp from 1,740 GBp at JPMorgan
03/04/21 Citi
Mondi price target raised to 2,100 GBp at Citi
NVS Novartis
$87.93 /

+0.28 (+0.32%)

05/11/21 Morgan Stanley
Novartis price target lowered to CHF 99 from CHF 102 at Morgan Stanley
04/28/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan
04/28/21 Oddo BHF
Novartis upgraded to Outperform from Neutral at Oddo BHF
04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
ORAN Orange
$12.83 /

+0.115 (+0.90%)

05/11/21 Morgan Stanley
Orange price target raised to EUR 11.50 from EUR 11 at Morgan Stanley
05/11/21 Goldman Sachs
Orange downgraded to Neutral from Buy at Goldman Sachs
05/05/21 JPMorgan
Orange price target raised to EUR 13 from EUR 12.50 at JPMorgan
04/12/21 Morgan Stanley
Orange price target lowered to EUR 11 from EUR 11.50 at Morgan Stanley
PDRDY Pernod Ricard
$43.43 /

+0.9255 (+2.18%)

04/26/21 JPMorgan
Pernod Ricard price target raised to EUR 190 from EUR 160 at JPMorgan
04/23/21 Barclays
Pernod Ricard price target raised to EUR 197 from EUR 195 at Barclays
04/23/21 Morgan Stanley
Pernod Ricard price target raised to EUR 187 from EUR 182 at Morgan Stanley
04/23/21 Credit Suisse
Pernod Ricard price target raised to EUR 183 from EUR 172 at Credit Suisse
SUBCY Subsea 7
$9.75 /

-0.13 (-1.32%)

04/30/21 UBS
Subsea 7 price target lowered to NOK 110 from NOK 115 at UBS
04/30/21 SEB Equities
Subsea 7 upgraded to Buy from Hold at SEB Equities
04/27/21 JPMorgan
Subsea 7 price target raised to NOK 113 from NOK 107 at JPMorgan
03/29/21 DNB Markets
Subsea 7 downgraded to Sell from Buy at DNB Markets
SXYAY Sika
$31.24 /

+0.562 (+1.83%)

05/17/21 Societe Generale
Sika price target raised to CHF 282 from CHF 265 at Societe Generale
04/27/21 UBS
Sika price target raised to CHF 270 from CHF 235 at UBS
04/21/21 Morgan Stanley
Sika price target raised to CHF 308 from CHF 300 at Morgan Stanley
04/21/21 Barclays
Sika price target raised to CHF 310 from CHF 300 at Barclays
VOPKY Koninklijke Vopak
$46.76 /

+0.83 (+1.81%)

05/03/21 Oddo BHF
Koninklijke Vopak downgraded to Neutral from Outperform at Oddo BHF
04/22/21 Credit Suisse
Koninklijke Vopak price target lowered to EUR 46 from EUR 50 at Credit Suisse
03/01/21 Kepler Cheuvreux
Koninklijke Vopak upgraded to Hold from Reduce at Kepler Cheuvreux
06/19/20 ABN Amro
Koninklijke Vopak upgraded to Buy from Hold at ABN Amro
NVS Novartis
$87.93 /

+0.28 (+0.32%)

GSK GlaxoSmithKline
$39.04 /

+0.327049 (+0.84%)

NVS Novartis
$87.93 /

+0.28 (+0.32%)

GSK GlaxoSmithKline
$39.04 /

+0.327049 (+0.84%)

NVS Novartis
$87.93 /

+0.28 (+0.32%)

GSK GlaxoSmithKline
$39.04 /

+0.327049 (+0.84%)

GSK GlaxoSmithKline
$39.04 /

+0.327049 (+0.84%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.